The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene

(2016) Victor Vogel   Clinical Interventions in Aging

The Aryl Hydrocarbon Receptor Complex and the Control of Gene Expression

(2012) Timothy V. Beischlag et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Expression and Activity of Aryl Hydrocarbon Receptors in Development and Cancer

(2012) Thomas A. Gasiewicz et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

Optimization of Adenosine 5′-Carboxamide Derivatives as Adenosine Receptor Agonists Using Structure-Based Ligand Design and Fragment Screening

(2012) Dilip K. Tosh et al.   JOURNAL OF MEDICINAL CHEMISTRY

AHR2 Mutant Reveals Functional Diversity of Aryl Hydrocarbon Receptors in Zebrafish

(2012) Britton C. Goodale et al.   PLoS One

The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells

(2012) Edmond F. O’Donnell et al.   PLoS One

A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women

(2010) Michael W. Draper et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor

(2010) Edmond F. O'Donnell et al.   PLoS One

The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice

(2009) Wayne A. Fritz et al.   BIOCHEMICAL PHARMACOLOGY

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

(2009) Balazs Györffy et al.   BREAST CANCER RESEARCH AND TREATMENT

The Aryl Hydrocarbon Receptor Functions as a Tumor Suppressor of Liver Carcinogenesis

(2009) Y. Fan et al.   CANCER RESEARCH

Modeling of the Aryl Hydrocarbon Receptor (AhR) Ligand Binding Domain and Its Utility in Virtual Ligand Screening to Predict New AhR Ligands

(2009) William H. Bisson et al.   JOURNAL OF MEDICINAL CHEMISTRY

Activation of the Aryl-Hydrocarbon Receptor Inhibits Invasive and Metastatic Features of Human Breast Cancer Cells and Promotes Breast Cancer Cell Differentiation

(2009) Julie M. Hall et al.   MOLECULAR ENDOCRINOLOGY

Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands

(2009) K. Kawajiri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: A tumor promoting event?

(2008) S. Ray et al.   BIOCHEMICAL PHARMACOLOGY

A Short Nur77-Derived Peptide Converts Bcl-2 from a Protector to a Killer

(2008) Siva Kumar Kolluri et al.   CANCER CELL

The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates

(2008) Wayne A. Fritz et al.   CARCINOGENESIS

Increased antitumor potential of the raloxifene prodrug, raloxifene diphosphate

(2008) Yoshinori Okamoto et al.   INTERNATIONAL JOURNAL OF CANCER

The combination of raloxifene and epigallocatechin gallate suppresses growth and induces apoptosis in MDA-MB-231 cells

(2008) Emma C. Stuart et al.   LIFE SCIENCES

Abnormal Liver Development and Resistance to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Toxicity in Mice Carrying a Mutation in the DNA-Binding Domain of the Aryl Hydrocarbon Receptor

(2008) Maureen K. Bunger et al.   TOXICOLOGICAL SCIENCES